We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
West Berkshire Brewery (WBB) have been brewing cask ales and bottled beers since 1995 and have won more than 40 awards. WBB use locally sourced ingredients and are trying to make their business as sustainable as possible.  
days to go: Expired investment: £1,765,482
Mercato Metropolitano represents a revival of traditional street food market with an Italian soul within the UK and beyond. The current London location has already attracted an estimated 590,000 people* through its doors since November 2016 to July 2017. Yet, MM is more than just a food market. The MM concept is proving popular because it offers visitors a trusted destination for friends to enjoy a fantastic range of highly-curated Mediterranean street food, artisan groceries to take home and inclusive entertainment, featuring an immersive cinema offering as well as local live music. What stands out for many visitors, is the relaxed atmosphere focused on the local community.
days to go: Expired investment: £577,587
BeneTalk is an innovative digital therapeutic solution, providing on-demand support to individuals who stutter and their families, aiming to enhance their quality of life and confidence. Stuttering affects millions globally, and with limited specialized therapy options, BeneTalk addresses accessibility challenges by offering timely assistance, aiming to mitigate the higher risk of low self-esteem and mental health issues faced by individuals who stutter and their families.
days to go: Expired investment: £173,123
Nutrifix is an app that locates healthy meals nearby or selects recipes or delivery options all tailored to you bodies needs. The app is like having a personal nutritionist in your pocket and is in a growing sector as the global value of mobile health solutions is set to reach 83,000,000,000 by 2022.

Pitch Rated

70%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £194,310
HealthBox Software is a technology company building products for the post-COVID healthcare landscape. Its first product, ClearPass, was met with success. The tool asks an employee a series of screening questions related to COVID-19, including evidence of fever, fatigue, and dry cough, etc. ClearPass has over 400,000 end-users including companies like Johnson Controls, Remy Cointreau and the San Diego School District. HealthBox aims to be a significant contender in the global digital health market that is expected to be worth $600 billion by 2026. The company is on the verge of launching another innovative product, MyHealthBox. It is a consumer-facing digital health app that will allow users to store their medical records, easily accessible 24/7. HealthBox asserts that the app will have an array of features, including AI health assessment services, dietary advice and data-powered lifestyle guidance. The company will use 47% of the investment towards technology and development costs, and 53% towards sales and marketing.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £144,265
Cranes Drinks is the fastest growing cider company in the UK, producing a range of innovative fruit ciders. By utilising the fruit’s natural sweetness, its drinks contain 30% fewer calories compared to that of brand leaders. Cranes ciders come in 3 flavours: blueberry & apple, cranberry & lime, and raspberry & pomegranate. As per Cranes, 34% of cider drinkers haven't consumed cider drinks much because it’s too sweet or has too much sugar. This makes Cranes a top contender in a growing fruit cider market worth £1.3 billion. The company's entire range is available on Ocado, and it has received 3 national listings in prominent retail chains like Sainsbury’s, Asda, and Morrisons. The brand has won 3 awards for its spirit range including a Gold Award in the Liqueur Masters organised by The Spirits Business and two awards from the International Wine & Spirits Competition. It has also received substantial media coverage in publications like Made In Chelsea, Dragons Dens, The Daily Telegraph, The Evening Standard, Vogue, Cosmopolitan, and Bella amongst others. With the investment, the company aims to use 25% of it as working capital, 60% in marketing, and 15% in managing key finances.

Pitch Rated

48%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £246,046
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph